Siemens Healthineers AG (ADR)
General ticker "SMMNY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $122.0B (TTM average)
Siemens Healthineers AG (ADR) follows the US Stock Market performance with the rate: 29.6%.
Estimated limits based on current volatility of 0.6%: low 25.13$, high 25.48$
Factors to consider:
- Company pays dividends (annually): last record date 2025-02-20, amount 0.52$ (Y2.04%)
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [23.72$, 36.15$]
- 2025-09-30 to 2026-09-30 estimated range: [24.80$, 37.69$]
Financial Metrics affecting the SMMNY estimates:
- Positive: with PPE of 19.3 at the end of fiscal year the price was neutral
- Positive: 7.86 < Operating profit margin, % of 14.76
- Negative: negative Industry operating cash flow (median)
- Positive: 18.93 < Shareholder equity ratio, % of 39.52 <= 41.86
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 4.08
- Positive: 0.33 < Operating cash flow per share per price, % of 4.39
- Positive: Interest expense per share per price, % of 0.85 <= 3.41
Short-term SMMNY quotes
Long-term SMMNY plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | €21,714.00MM | €21,680.00MM | €22,363.00MM |
| Operating Expenses | €18,650.00MM | €19,240.00MM | €19,063.00MM |
| Operating Income | €3,064.00MM | €2,440.00MM | €3,300.00MM |
| Non-Operating Income | €-264.00MM | €-512.00MM | €-777.00MM |
| Interest Expense | €118.00MM | €296.00MM | €476.00MM |
| R&D Expense | €1,785.00MM | €1,866.00MM | €1,918.00MM |
| Income(Loss) | €2,800.00MM | €1,928.00MM | €2,523.00MM |
| Taxes | €746.00MM | €403.00MM | €564.00MM |
| Profit(Loss)* | €2,038.00MM | €1,509.00MM | €1,942.00MM |
| Stockholders Equity | €19,836.00MM | €18,081.00MM | €18,199.00MM |
| Inventory | €4,009.00MM | €4,294.00MM | €4,179.00MM |
| Assets | €49,056.00MM | €46,684.00MM | €46,055.00MM |
| Operating Cash Flow | €2,256.00MM | €1,809.00MM | €2,469.00MM |
| Capital expenditure | €852.00MM | €838.00MM | €696.00MM |
| Investing Cash Flow | €-868.00MM | €-1,069.00MM | €-666.00MM |
| Financing Cash Flow | €-1,396.00MM | €-380.00MM | €-1,300.00MM |
| Earnings Per Share** | €0.91 | €0.67 | €0.87 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.